Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison

Breadcrumb

  • Home
  • Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison

Deborah Aanuoluwa Soyombo *

Milky Express Nigeria Limited, Lagos, Nigeria.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 001–011.
Article DOI: 10.30574/wjbphs.2024.18.1.0165
DOI url: https://doi.org/10.30574/wjbphs.2024.18.1.0165

Received on 23 February 2024; revised on 01 April 2024; accepted on 03 April 2024

Navigating regulatory challenges and ensuring safety in the development of lactation supplements is crucial for meeting the needs of breastfeeding mothers. This review examines the regulatory frameworks governing lactation supplements in Nigeria and the US, highlighting key differences and similarities, as well as challenges and strategies for ensuring product safety and compliance. In Nigeria, the regulatory landscape for lactation supplements is characterized by a lack of stringent regulations and enforcement mechanisms, leading to concerns about product safety and quality. In contrast, the US has a well-established regulatory framework overseen by the Food and Drug Administration (FDA), which sets strict standards for product safety, efficacy, and labeling. Challenges in Nigeria include limited regulatory capacity, inadequate enforcement of existing regulations, and a lack of awareness among consumers about product safety. In the US, challenges include the complex regulatory process, high compliance costs, and the need for continuous monitoring of safety and efficacy. Strategies for ensuring product safety and compliance in Nigeria include strengthening regulatory capacity, improving enforcement mechanisms, and raising awareness among consumers about safe product choices. In the US, strategies include streamlining the regulatory process, enhancing post-market surveillance, and fostering collaboration between regulators, industry stakeholders, and healthcare providers. Overall, navigating regulatory challenges and ensuring safety in the development of lactation supplements require a multifaceted approach that addresses regulatory gaps, enhances enforcement mechanisms, and promotes consumer awareness. Collaboration between regulatory authorities, industry stakeholders, and healthcare providers is essential to ensure that lactation supplements are safe, effective, and meet the needs of breastfeeding mothers in Nigeria and the US.

Safety Consideration; Lactation; supplement; Development; Regulatory Challenges

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0165.pdf

Preview Article PDF

Deborah Aanuoluwa Soyombo. Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison. World Journal of Biology Pharmacy and Health Sciences, 2024, 18(01), 001–011. Article DOI: https://doi.org/10.30574/wjbphs.2024.18.1.0165

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution